Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 85051 - 85075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Troglitazone	Approved Withdrawn	KIF23	9493	downregulated	troglitazone results in decreased expression of KIF23 mRNA	15q23	A24633
Troglitazone	Approved Withdrawn	KIF24	347240	downregulated	troglitazone results in decreased expression of KIF24 mRNA	9p13.3	A24633
Troglitazone	Approved Withdrawn	KIF2C	11004	downregulated	troglitazone results in decreased expression of KIF2C mRNA	1p34.1	A24633
Troglitazone	Approved Withdrawn	KIF4A	24137	downregulated	troglitazone results in decreased expression of KIF4A mRNA	Xq13.1	A24633
Troglitazone	Approved Withdrawn	KLF6	1316	upregulated	troglitazone results in increased expression of KLF6 mRNA	10p15.2	A24633
Troglitazone	Approved Withdrawn	KLHL5	51088	upregulated	troglitazone results in increased expression of KLHL5 mRNA	4p14	A24633
Troglitazone	Approved Withdrawn	KLK3	354	downregulated	troglitazone results in decreased expression of KLK3 mRNA	19q13.33	A24635
Troglitazone	Approved Withdrawn	KLKB1	3818	downregulated	troglitazone results in decreased expression of KLKB1 mRNA	4q35.2	A22609
Troglitazone	Approved Withdrawn	KNTC1	9735	downregulated	troglitazone results in decreased expression of KNTC1 mRNA	12q24.31	A24633
Troglitazone	Approved Withdrawn	KRT8	3856	downregulated	troglitazone results in decreased expression of KRT8 mRNA	12q13.13	A24633
Troglitazone	Approved Withdrawn	LAMA4	3910	upregulated	troglitazone results in increased expression of LAMA4 mRNA	6q21	A24633 A22609
Troglitazone	Approved Withdrawn	LARP6	55323	upregulated	troglitazone results in increased expression of LARP6 mRNA	15q23	A24633
Troglitazone	Approved Withdrawn	LDHB	3945	upregulated	troglitazone results in increased expression of LDHB mRNA	12p12.1	A22609
Troglitazone	Approved Withdrawn	LDLR	3949	downregulated	[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA	19p13.2	A24660
Troglitazone	Approved Withdrawn	LDLR	3949	downregulated	troglitazone results in decreased expression of LDLR mRNA	19p13.2	A22609
Troglitazone	Approved Withdrawn	LDLR	3949	upregulated	troglitazone results in increased expression of LDLR mRNA	19p13.2	A24661
Troglitazone	Approved Withdrawn	LIF	3976	upregulated	troglitazone results in increased expression of LIF mRNA	22q12.2	A24633
Troglitazone	Approved Withdrawn	LIG1	3978	downregulated	troglitazone results in decreased expression of LIG1 mRNA	19q13.33	A24633
Troglitazone	Approved Withdrawn	LPIN1	23175	downregulated	troglitazone results in decreased expression of LPIN1 mRNA	2p25.1	A22609
Troglitazone	Approved Withdrawn	LPP	4026	upregulated	troglitazone results in increased expression of LPP mRNA	3q27.3-q28	A24633
Troglitazone	Approved Withdrawn	LSS	4047	downregulated	troglitazone results in decreased expression of LSS mRNA	21q22.3	A22609
Troglitazone	Approved Withdrawn	LTA	4049	upregulated	troglitazone results in increased expression of LTA mRNA	6p21.33	A24107
Troglitazone	Approved Withdrawn	LTBP4	8425	upregulated	troglitazone results in increased expression of LTBP4 mRNA	19q13.1-q13.2	A24633
Troglitazone	Approved Withdrawn	LY96	23643	upregulated	troglitazone results in increased expression of LY96 mRNA	8q21.11	A22609
Troglitazone	Approved Withdrawn	MAD2L1	4085	downregulated	troglitazone results in decreased expression of MAD2L1 mRNA	4q27	A24633

Displaying entries 85051 - 85075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability